Ebdarokimab
Product Specifications
CAS Number
2393651-11-9
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.994
Bioactivity
Ebdarokimab is a fully human monoclonal antibody (mAb) designed to inhibit the IL-12/IL-23 pathway through its highly specific binding to the shared p40 subunit common to both interleukin-12 and interleukin-23 cytokines, resulting in the potent inhibition of their downstream signaling cascades. Ebdarokimab can be used in studies about systemic lupus erythematosus (SLE) and severe plaque psoriasis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
129405-AP 100 µL
MAPK6 (Mitogen-activated Protein Kinase 6, MAP Kinase 6, MAPK 6, Extracellular Signal-regulated Kinase 3, ERK-3, MAP Kinase Isoform p97, p97-MAPK, ERK3, PRKM6, DKFZp686F03189) (AP) discontinued
Sign In for Pricing
View Details 
LV793104 1.0 µg DNA
TMED7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details MBS1287404-01 0.02 mg (E-Coli)
Recombinant Nitrosospira multiformis Glucose-1-phosphate adenylyltransferase (glgC)
Sign In for Pricing
View Details MBS1287404-02 0.02 mg (Yeast)
Recombinant Nitrosospira multiformis Glucose-1-phosphate adenylyltransferase (glgC)
Sign In for Pricing
View Details 
MBS1287404-03 0.1 mg (E-Coli)
Recombinant Nitrosospira multiformis Glucose-1-phosphate adenylyltransferase (glgC)
Sign In for Pricing
View Details